Triomics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Triomics, Inc. - overview
Established
2021
Location
New York, NY, US
Primary Industry
Healthcare IT
About
Founded in 2021 by Hrituraj Singh, Sajjan Rajpurohit, and Sarim Khan, and based in San Francisco, California, Triomics, Inc. operates as a healthcare platform that provides oncology technology solutions, specializing in generative artificial intelligence for oncology research and care. In May 2026, Triomics, Inc. raised USD 22 million in series B funding led by Battery Ventures, with participation from Oncology Ventures, Lightspeed Venture Partners, Nexus Venture Partners, Precision Health Informatics and Y Combinator.
Triomics provides a generative AI-powered platform designed to support cancer care providers by leveraging health record data. The platform also assists in accelerating trial enrollment, improving quality, and streamlining healthcare operations. The firm uses AI technology, trained to understand health records and medical terminology to enhance operational efficiency in oncology. The company intends to use the May 2026 funding to expand its artificial intelligence platform across cancer centers, hire engineering teams, and develop tools for clinical care and research.
Current Investors
Nexus Venture Partners, Lightspeed Venture Partners, General Catalyst Partners
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Medical Software
Website
www.triomics.com
Verticals
Artificial Intelligence, Cloud Computing, HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Triomics, Inc. - timeline of key events
Triomics, Inc. - financials
| Fiscal Year Ended | Mar 31, 2021 | Mar 31, 2022 |
|---|---|---|
| Revenue (USD) | - | - |
| % Revenue Growth (YoY) | - | - |
| EBITDA (USD) | - | - |
| Operating Income (USD) | - | - |
| Operating Margin | - | - |
| % EBITDA Margin | - | - |
| NET Income (USD) | - | - |
| % Net Margin | - | - |
Triomics, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.